MeSH D018798 - iron-deficiency anemia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D000090463:Iron deficiencies
0 Companies
0 Drugs
Success rate
D000747:Hypochromic anemia
0 Companies
0 Drugs
Success rate
D018798:
Iron-deficiency anemia
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| American Regent | Iron sucrose | Venofer | 2000-11-06 | |||
| Covis Pharma | Ferumoxytol | Feraheme | 2023-06-30 | 2009-06-30 | ||
| Norgine | Ferric maltol | Feraccru | 2016-02-18 | |||
| Pharmacosmos | Ferric derisomaltose | Monoferric | 2029-03-25 | 2020-01-16 | ||
| Sandoz | Ferumoxytol | Ferumoxytol | 2021-01-15 | |||
| Takeda | Ferumoxytol | Rienso | 2012-06-15 |
Clinical Trials
Historical Success Rate
Phase 1
73%11/15
Phase 2
90%9/10
Phase 3
73%11/15
Approved: 3Overall Success rate: 48%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use